Activities per year
Activities
- 50 - 100 out of 213 results
Search results
-
Acquired APC resistance as a marker for VTE, how reliable?
Douxfils, J. (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Douxfils, J. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Douxfils, J. (Speaker) & Chatel, G. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Douxfils, J. (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Linking platelet lipid metabolism and thrombosis: Role of acetyl-CoA carboxylase
Douxfils, J. (Jury Member)
25 Aug 2022Activity: Examinations › External Thesis
-
ISTH 2022 Congress
Morimont, L. (Participant), Didembourg, M. (Participant) & Douxfils, J. (Participant)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Douxfils, J. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
ISTH 2022 Congress
Douxfils, J. (Contributor)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Douxfils, J. (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Douxfils, J. (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Douxfils, J. (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
16th ESC congress
Morimont, L. (Participant) & Douxfils, J. (Contributor)
25 May 2022 → 28 May 2022Activity: Participating in or organising an event types › Participation in conference
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Morimont, L. (Contributor), Evrard, J. (Contributor), Siriez, R. (Contributor), Douxfils, J. (Contributor), Didembourg, M. (Participant), GILLOT, C. (Participant), Djokoto, H. (Participant) & Haguet, H. (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Douxfils, J. (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Douxfils, J. (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Measurement of Direct Oral Anticoagulants and Contact Pathway Inhibitors
Douxfils, J. (Invited speaker)
18 Jul 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients After Two Doses of BNT162b2
Favresse, J. (Invited speaker) & Douxfils, J. (Invited speaker)
7 Jun 2021Activity: Talk or presentation types › Invited talk
-
Thrombotic risk associated with COVID- 19 pathogenesis and unusual thrombosis associated with thrombocytopenia in the context of COVID-19 vaccination
Douxfils, J. (Invited speaker)
24 Jun 2021Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): Impact on hemostasis
Douxfils, J. (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Contribution des techniques de coagulation à la compréhension de la physiologie et de la physiopathologie de l’hémostase – Applications cliniques
Douxfils, J. (Jury Member)
4 May 2021Activity: Examinations › External Thesis
-
Neutralizing antibodies in COVID-19: Current knowledge and perspectives
Douxfils, J. (Invited speaker)
16 Mar 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Douxfils, J. (Invited speaker) & Morimont, L. (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk
-
Utilisation des tests chromogéniques anti-FXa dans le cadre du suivi de l’HNF et des HBPM: principes de base et recommandations
Douxfils, J. (Invited speaker)
9 Feb 2021Activity: Talk or presentation types › Invited talk
-
Fund for Research Training in Industry and Agriculture (FRIA) (External organisation)
Douxfils, J. (Chair)
2021 → 2024Activity: Examinations › Jury
-
Restoring faith in COC - An important hemostasis update
Douxfils, J. (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Jury de la Commission FRIA LS04 - jury 2
Douxfils, J. (Supervisor)
14 Oct 2020Activity: Examinations › Jury
-
Monitoring of anticoagulant drugs
Douxfils, J. (Speaker)
16 Sept 2020Activity: Talk or presentation types › Invited talk
-
How to Measure Lupus Anticoagulants During DOAC Treatment?
Douxfils, J. (Speaker)
12 Jul 2020Activity: Talk or presentation types › Invited talk
-
Jury de la Commission FRIA LS04 - jury 2
Douxfils, J. (Supervisor)
4 Nov 2019Activity: Examinations › Jury
-
Pilule et thrombose : risques et contrôle biologique
Douxfils, J. (Speaker)
14 Oct 2019Activity: Talk or presentation types › Invited talk
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians and lab scientists
Douxfils, J. (Speaker)
22 Oct 2019Activity: Talk or presentation types › Invited talk
-
ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis
Douxfils, J. (Invited Speaker)
6 Jul 2019 → 10 Jul 2019Activity: Participating in or organising an event types › Participation in conference
-
-
ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis
Douxfils, J. (Member of Scientific Committee)
6 Jul 2019 → 10 Jul 2019Activity: Participating in or organising an event types › Participation in conference
-
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Douxfils, J. (Invited speaker)
9 Jul 2019Activity: Talk or presentation types › Oral presentation
-
24th Congress of EHA
Douxfils, J. (Invited Speaker)
13 Jun 2019 → 16 Jun 2019Activity: Participating in or organising an event types › Participation in conference
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Douxfils, J. (Invited speaker)
20 Jun 2019Activity: Talk or presentation types › Oral presentation
-
26th International Congress on Thrombosis
Douxfils, J. (Invited Speaker)
19 Jun 2019 → 22 Jun 2019Activity: Participating in or organising an event types › Participation in conference
-
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Douxfils, J. (Invited speaker)
14 Jun 2019Activity: Talk or presentation types › Oral presentation
-
The Impact of Oral Anticoagulants on Haemostasis: a Step Towards Individualized Therapy
Douxfils, J. (Jury Member)
3 May 2019Activity: Examinations › External Thesis
-
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Douxfils, J. (Invited speaker)
19 Mar 2019Activity: Talk or presentation types › Invited talk
-
Affections thromboemboliques veineuses – partie II
Douxfils, J. (Keynote speaker)
12 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
9ème Symposium du Namur Thrombosis and Hemostasis Center
Douxfils, J. (Member of Scientific Committee)
21 Mar 2019Activity: Participating in or organising an event types › Participation in workshop, seminar, course
-
12th Annual Congress of the European Association for Haemophilia and Allied Disorders
Douxfils, J. (Keynote Speaker)
6 Feb 2019 → 8 Feb 2019Activity: Participating in or organising an event types › Participation in conference
-
British Journal of Haematology (Journal)
Douxfils, J. (Peer reviewer)
2019 → …Activity: Publication peer-review and editorial work types › Publication peer-review